Overseas Headlines – December 24, 2024

December 24, 2024

United States:

Fed Seeks to Smooth Capital Changes in Bank Stress Tests

 

The   US Federal Reserve will overhaul its stress tests of big US banks to smooth out changes in required capital levels from year to year under a proposal outlined by the central bank on Monday.

 

Results from the annual health check-up, which seek to gauge how lenders would fare during a hypothetical recession, would be averaged over two years, and the central bank would solicit public comment on the hypothetical scenarios each year before they’re finalized, the Fed said in its release.

 

https://www.bloomberg.com/news/articles/2024-12-23/fed-to-seek-public-comment-on-bank-stress-test-changes?srnd=phx-markets

 

Europe:

ECB Very Close to Meeting 2% Inflation Target, Lagarde Tells FT

The European Central Bank is nearing its consumer-price target but must remain alert to lingering dangers in some sectors, according to President Christine Lagarde.

 

“We’re getting very close to that stage when we can declare that we have sustainably brought inflation to our medium-term 2%,” Lagarde said in an FT podcast released Monday. “I’m saying that with a little reservation because I still believe that we should be very vigilant about services.”

 

https://www.bloomberg.com/news/articles/2024-12-23/ecb-very-close-to-meeting-2-inflation-target-lagarde-tells-ft

 

Asia:

China Mulls Record $411 Billion Special Bonds, Reuters Says

 

China’s policymakers plan to sell a record 3 trillion yuan ($411 billion) of special treasury bonds in 2025, Reuters reported on Tuesday, a move aimed at bolstering the slowing economy.

 

The plan would be a sharp increase from this year’s 1 trillion yuan and be used to support consumption and investments as well as recapitalizing large state banks, according to Reuters, citing two unnamed sources.

 

https://www.bloomberg.com/news/articles/2024-12-24/china-plans-to-issue-411-billion-special-bonds-reuters-says

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_609342323
March 25, 2026   Sagicor Group Jamaica Limited (SJ) has declared a dividend of $0.89 per stock unit payable on May 6, 2026, to stockholders…
shutterstock_148562033
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that a senior officer purchased 276,992 PJAM shares on March 24, 2026. &…
shutterstock_453968572
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that on March 24, 2026, three Directors were issued a total of 50,634 PJAM sh…
shutterstock_148562033
March 25, 2026   Supreme Ventures Limited (SVL) has advised that on March 17, 2026, a Director purchased 319,424 SVL shares and a related e…
shutterstock_148562033
March 25, 2026   IronRock Insurance Company Limited (ROC) has advised that connected parties sold a total of 70,939 ROC shares during the p…
shutterstock_453968572
March 25, 2026 United States: US Import Prices Jumped by the Most Since 2022 Ahead of War   The cost of imports into the US jumped in Febr…
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…